☆ 4.7 Review

Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Tania Rodrigues et al.

Summary: A systematic review and subgroup analysis showed that fecal microbial transplantation (FMT) may be an effective treatment for irritable bowel syndrome (IBS), especially through gastroscopy or nasojejunal tube. Furthermore, FMT appears to be more effective for IBS patients with constipation symptoms, and the freshness of the fecal transplant and bowel preparation also influence FMT efficacy.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

Babu P. Mohan et al.

Summary: This study investigated the clinical outcomes of fecal microbiota transplant (FMT) delivered via invasive routes for irritable bowel syndrome (IBS) through a systematic review and meta-analysis. The results showed that FMT can significantly improve symptoms of IBS, especially when performed via colonoscopy.

INDIAN JOURNAL OF GASTROENTEROLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients An Updated Systematic Review and Meta-Analysis

Amal Mohamed Elhusein et al.

Summary: This systematic review and meta-analysis examined the efficacy of fecal microbiota transplantation (FMT) in treating irritable bowel syndrome (IBS) patients. The results showed that FMT was effective in improving the quality of life and reducing symptoms and severity scoring in IBS patients, but no significant difference was found compared to placebo in terms of symptom improvement.

GASTROENTEROLOGY NURSING (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

Karen M. J. Waller et al.

Summary: FMT has become an established treatment for recurrent Clostridioides difficile infection and induction of remission for mild-moderate ulcerative colitis, but limited and conflicting data are available for other indications. Research is ongoing to explore the role of FMT in various conditions, while its mechanisms remain incompletely understood.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation

Tarek Mazzawi et al.

Summary: This study aimed to investigate the effect of fecal microbiota transplantation (FMT) on colonic enteroendocrine cells densities in patients with irritable bowel syndrome (IBS). The results showed significant changes in colonic enteroendocrine cells densities in the group of responders who received donor-FMT. However, the mechanisms behind the interaction between gut microbiota and colonic enteroendocrine cells still need further investigation.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Review Microbiology

Recent Advances in Understanding the Structure and Function of the Human Microbiome

Walaa K. Mousa et al.

Summary: This article discusses the composition of the human microbiome, the relationship between microbiome dysbiosis and diseases, and the opportunities for new microbiome-based therapeutics. Despite significant advances in microbiome research, our understanding is limited due to the personalized nature of the microbiome and its complex interactions with the host.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study

Vivek C. Goodoory et al.

Summary: This study found that the natural history of irritable bowel syndrome (IBS) defined according to the Rome IV criteria is more severe compared to IBS defined by the Rome III criteria. Approximately 60% of the participants met the Rome IV criteria, while approximately 40% met the Rome III criteria. Individuals with Rome IV IBS were more likely to seek medical care, start new treatments, and have more treatment cycles compared to those with Rome III IBS. Additionally, Rome IV IBS patients had more severe symptoms, greater impact on daily activities, and poorer psychological health.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D

Prashant Singh et al.

Summary: Fecal microbiota transplantation is an effective strategy to correct microbial dysbiosis in diarrhea-predominant irritable bowel syndrome. For patients with IBS-D, FMT with antibiotic pretreatment significantly reduces bacterial engraftment.

GUT MICROBES (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions

Pouyan Ghaffari et al.

Summary: This article summarizes the research progress on the microbiome in irritable bowel syndrome (IBS), pointing out the lack of established microbial mechanisms and clear treatment methods for IBS. The review proposes a new treatment perspective, using data-driven approach and computational modeling to design microbiome-aware personalized treatment strategies.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Microbiota medicine: towards clinical revolution

Prisca Gebrayel et al.

Summary: The human gastrointestinal tract is home to a large microbial community called gut microbiota, which plays important roles in immune function, nutrient absorption, and protection against pathogens. The interaction between gut microbiota and various organs within the human body is bidirectional, and microbial alteration has been shown to be a key factor in the pathogenesis of many diseases. Understanding the mechanisms behind gut microbial symbiosis/dysbiosis is crucial for clinical and health fields.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Review Immunology

Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review

Yeganeh Farsi et al.

Summary: This study demonstrates significant differences in gut microbiome composition between COVID-19 patients and healthy individuals, suggesting that the gut microbiota may serve as a potential diagnostic, prognostic, and therapeutic strategy for COVID-19.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials

Jie Wu et al.

Summary: The meta-analysis examined the efficacy of fecal microbiota transplantation (FMT) in irritable bowel syndrome (IBS) and found inconsistent results. FMT administered via colonoscopy or gastroscope may benefit IBS patients and improve their quality of life. However, the quality of evidence supporting the use of FMT in IBS is very low.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis

Chao-Rong Xie et al.

Summary: This study evaluated the most effective approaches for managing irritable bowel syndrome (IBS) by analyzing different combinations and components of probiotics or a low FODMAP diet. The results showed that Lactobacillus was the most effective component for relieving IBS symptoms, while Bifidobacterium and Bacillus were potentially effective and require further verification.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Immunology

The function of gut microbiota in immune-related neurological disorders: a review

Panida Sittipo et al.

Summary: This review highlights the importance of microbiota in regulating gut-brain communication in immune-related neurological disorders. The bidirectional communication between gut microbiota and the brain affects human health and behavior, particularly in neurological disorders. Despite numerous studies, there are still limitations in translating this research to humans.

JOURNAL OF NEUROINFLAMMATION (2022)

添加到收藏夹

Review Immunology

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

Mohammad Reza Hatamnejad et al.

Summary: IBD is a chronic inflammatory disease that poses a growing health problem. The use of anti-depressants as a routine regimen for IBD patients is not officially approved, but some physicians prescribe them empirically to alleviate symptoms. However, the prescription of SSRIs may come with adverse effects such as sleep disturbances, and there is evidence suggesting that prolonged use of SSRIs can worsen the IBD course. Despite the need for further research, periodic prescriptions of SSRIs at monthly intervals may be recommended for IBD patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial

Tom Holvoet et al.

Summary: Fecal microbiota transplantation (FMT) therapy has shown promising efficacy in treating patients with treatment-resistant Irritable Bowel Syndrome (IBS), particularly in relieving predominant bloating symptoms. The treatment response was associated with higher microbiome diversity in stool samples before FMT administration, suggesting a potential biomarker for patient selection.

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome

Brigida Barberio et al.

Summary: The study found that among individuals self-identifying as having IBS, the diagnosis and subtype of IBS were less stable, and starting new treatments did not affect symptom stability.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Nutrition & Dietetics

Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome

Haiyan Xu et al.

Summary: This study found that adjunctive use of probiotics with a routine regimen for IBS management showed additional clinical effectiveness compared to using the routine regimen alone. The probiotic adjunctive treatment significantly decreased IBS symptom severity score, levels of harmful bacterial genera, and levels of beneficial bacterial genera in IBS patients.

EUROPEAN JOURNAL OF NUTRITION (2021)

添加到收藏夹

Article Nutrition & Dietetics

The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study

Barbara Skrzydlo-Radomanska et al.

Summary: The study found that multi-strain probiotic intervention significantly improved symptoms and quality of life in patients with IBS-D, with good tolerance and safety.

NUTRIENTS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules

Qingqing Guo et al.

Summary: FMT therapy shows potential for alleviating clinical symptoms and restoring intestinal micro-ecology in IBS-D patients with comorbid anxiety and depression.

BIOENGINEERED (2021)

添加到收藏夹

Review Microbiology

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome

Tomasz Wollny et al.

Summary: Irritable bowel syndrome (IBS) is a common, chronic, functional disorder that impacts a large proportion of the world population, with its pathophysiology not fully understood. Emerging evidence suggests that gut microbiota plays a significant role in the development of IBS, and therefore targeting microbial modulation may effectively enhance therapy.

PATHOGENS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome

Prashant Singh et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome

V. Ivashkin et al.

Summary: This study aimed to evaluate the changes in gut microbiome composition, tight junction proteins, and cytokines expression from the duodenum to the distal part of the colon in IBS patients and healthy volunteers. The results showed significantly increased expression of IL-2 and TNF-alpha in IBS patients, with decreased expression of IL-10, CLD-3, and CLD-5, as well as altered ratios of Bacteroidetes and Firmicutes in the gut microbiota of IBS patients compared to controls.

PLOS ONE (2021)

添加到收藏夹

Review Nutrition & Dietetics

Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome

Elemer Simon et al.

Summary: This paper delves into the pathophysiologic mechanisms of irritable bowel syndrome (IBS) and the role of prebiotics, probiotics, and synbiotics in alleviating symptoms. It highlights the importance of technological advancements in understanding the role of probiotics in IBS therapy, and discusses clinical studies testing the efficacy and outcomes of synbiotics as therapy for IBS.

NUTRIENTS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review

Agnieszka Chlebicz-Wojcik et al.

Summary: Irritable bowel syndrome is not life-threatening but significantly impacts quality of life and economic loss. Research focuses on the role of intestinal microbiota in disease development, with an emphasis on therapies modulating the microbiota such as probiotics, prebiotics, and synbiotics. Most studies have focused on probiotics, but there are also promising results from studies on prebiotics and synbiotics.

BIOMOLECULES (2021)

添加到收藏夹

Article Medicine, General & Internal

Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study

Jiaqu Cui et al.

Summary: This study aimed to investigate the long-term efficacy of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS). The results from a 60-month follow-up period established the safety and efficacy of FMT for IBS, but highlighted the need for periodic and repetitive treatments to maintain the sustained effect.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Fecal Microbiota Transplantation: Is It Safe?

Seon-Young Park et al.

Summary: Fecal microbiota transplantation (FMT) is commonly used to manage recurrent Clostridioides difficile infections and is generally considered safe, but causality for microbiome-associated diseases needs further investigation. Recent serious adverse events associated with FMT products from stool banks highlight the importance of stricter donor screening protocols.

CLINICAL ENDOSCOPY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020

Cicilia Marcella et al.

Summary: The study evaluated the safety of FMT by summarising reported Adverse Events over a 20-year period, finding that most FMT-related AEs were mild or moderate and self-limiting. Serious adverse events mainly occurred in patients with mucosal barrier injury, indicating the importance of improving FMT methodology to reduce such risks.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Review Nutrition & Dietetics

Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

Lin Wang et al.

JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Magdy El-Salhy et al.

GUT (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

Perttu Lahtinen et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Review Medicine, General & Internal

An approach to the care of patients with irritable bowel syndrome

Adam D. Farmer et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Delivery routes for faecal microbiota transplants: Available, anticipated and aspired

Monica Gulati et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome

Rasmus Goll et al.

GUT MICROBES (2020)

添加到收藏夹

Review Medicine, General & Internal

Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives

Hanna Fjeldheim Dale et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis

Jessica Emily Green et al.

GUT MICROBES (2020)

添加到收藏夹

Review Infectious Diseases

Benefits of fecal microbiota transplantation: A comprehensive review

Muluneh Ademe

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders

Andrea Shin et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Review Medicine, General & Internal

Fecal microbiota transplantation: Review and update

Jiunn-Wei Wang et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

Gianluca Ianiro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota

Hong Li Huang et al.

JOURNAL OF DIGESTIVE DISEASES (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study

Savanne Holster et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)

添加到收藏夹

Article Nutrition & Dietetics

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)

Magdy El-Salhy et al.

NUTRIENTS (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

Kanchana Myneedu et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Olga C. Aroniadis et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Is there any association between gut microbiota and type 1 diabetes? A systematic review

Parnian Jamshidi et al.

GUT PATHOGENS (2019)

添加到收藏夹

Review Oncology

Fecal microbiota transplantation in cancer management: Current status and perspectives

Danfeng Chen et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Dabo Xu et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Article Biology

The distribution of bacterial doubling times in the wild

Beth Gibson et al.

PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Fecal microbiota transplantation for managing irritable bowel syndrome

Magdy El-Salhy et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome

Joanna Dionne et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

Tarek Mazzawi et al.

PLOS ONE (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial

Peter Holger Johnsen et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation

Stephen M. Vindigni et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)

添加到收藏夹

Article Medicine, General & Internal

Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection A Randomized Clinical Trial

Dina Kao et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Review Medicine, General & Internal

Irritable Bowel Syndrome

Alexander C. Ford et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Irritable bowel syndrome: a gut microbiota-related disorder?

Yogesh Bhattarai et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Bowel Disorders

Brian E. Lacy et al.

GASTROENTEROLOGY (2016)

添加到收藏夹

Review Medicine, General & Internal

Irritable Bowel Syndrome A Clinical Review

William D. Chey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Alexander C. Ford et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Brain-Gut Microbiome Interactions and Functional Bowel Disorders

Emeran A. Mayer et al.

GASTROENTEROLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

The Long-Term Stability of the Human Gut Microbiota

Jeremiah J. Faith et al.

SCIENCE (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Fecal microbiota transplantation and emerging applications

Thomas J. Borody et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)

添加到收藏夹

Article Gastroenterology & Hepatology

Treating Clostridium difficile Infection With Fecal Microbiota Transplantation

Johan S. Bakken et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

添加到收藏夹

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

添加到收藏夹

Review Microbiology

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

Anne Salonen et al.

MICROBIOLOGY-SGM (2010)

添加到收藏夹

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.